Effect of obesity on coronary collateral vessel development in patients with coronary artery disease

Ersan Tatli1, Mustafa Yildiz, Cetin Gül

  • 1Department of Cardiology, School of Medicine, Trakya University, Edirne, Turkey. ersantatli@hotmail.com

Angiology
|December 6, 2005
PubMed

Insights

This study found that while obesity and overweight patients had more risk factors, coronary collateral circulation was not significantly affected in obese patients with coronary artery disease. Further research is needed to understand this complex relationship.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Metabolic Syndrome

Background:

  • Coronary artery disease (CAD) is a leading cause of mortality worldwide.
  • Coronary collateral circulation (CCC) plays a crucial role in mitigating ischemic damage.
  • The relationship between body mass index (BMI) and CCC in CAD patients remains incompletely understood.

Purpose of the Study:

  • To investigate the association between different body mass index (BMI) categories and coronary collateral circulation (CCC) in patients with coronary artery disease (CAD).
  • To compare the prevalence of cardiovascular risk factors among different BMI groups in the study population.

Main Methods:

  • A retrospective analysis of 90 first-time angiography patients with single-vessel CAD between January 1999 and December 2001.
  • Patients were categorized by BMI (normal, overweight, obese) and CCC (insufficient vs. sufficient).
  • Data on age, sex, smoking, hypertension, diabetes mellitus, hyperlipidemia, preinfarction angina, and medication use were collected and analyzed.

Main Results:

  • Obesity and overweight groups exhibited higher frequencies of hyperlipidemia, diabetes mellitus, and nitrate use (p < 0.05).
  • Use of oral nitrates >6 months pre-myocardial infarction and preinfarction angina positively influenced collateral coronary vessel development (p = 0.01, p = 0.03).
  • No statistically significant correlation was found between CAD and CCC development in obese patients (p = 0.6), despite a trend towards negative impact.

Conclusions:

  • While obese patients with CAD showed a trend towards impaired collateral vessel development, this did not reach statistical significance in this cohort.
  • Cardiovascular risk factors like hyperlipidemia and diabetes were more prevalent in overweight and obese individuals.
  • Preinfarction angina and long-term nitrate use were associated with better collateralization, suggesting potential therapeutic implications.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...